|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alcohol-Related Disorders | |||||
| Cocaine-Related Disorders | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Disorders of Environmental Origin | |||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| Substance-Related Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Naltrexone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Central Nervous System Agents | |||||
| Narcotic Antagonists | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Drug Abuse (NIDA) | |||||
| University of Texas | |||||